Dr. Nahm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7695 Cardinal Ct
Ste 200
San Diego, CA 92123Phone+1 858-278-8835Fax+1 858-386-4776
Education & Training
Boston University Medical CenterResidency, Dermatology, 1999 - 2002
St. Joseph Medical CenterInternship, Transitional Year, 1998 - 1999
Baylor College of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2002 - 2025
TX State Medical License 2000 - 2004- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Clinical Trials
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
- LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 55 citationsObjective changes in brow position, superior palpebral crease, peak angle of the eyebrow, and jowl surface area after volumetric radiofrequency treatments to half of t...Walter K. Nahm, Thomas T. Su, Adam M. Rotunda, Ronald L. Moy
Dermatologic Surgery. 2004-06-01 - 4 citationsTargeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years.Emma Guttman-Yassky, Kenji Kabashima, Delphine Staumont-Salle, Walter K Nahm, Sylvia Pauser
Allergy. 2024-06-01 - 8 citationsResults of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulg...Lawrence F. Eichenfield, Linda Stein Gold, Walter K. Nahm, Fran E Cook-Bolden, David M. Pariser
Journal of Drugs in Dermatology. 2016-12-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
